Treeline Biosciences, Inc.
Clinical trials sponsored by Treeline Biosciences, Inc., explained in plain language.
-
New drug targets tough KRAS cancers in first human trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called TLN-372, both alone and combined with other cancer treatments, in people with advanced solid tumors driven by a specific KRAS gene mutation. The main goals are to find a safe dose, see how the drug moves through the body, and ch…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New hope for lymphoma patients as experimental drug enters human testing
Disease control Recruiting nowThis early-stage trial is testing a new drug called TLN-121 for people with non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and when combined …
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for Tough-to-Treat lymphoma: early drug trial opens
Disease control Recruiting nowThis early-stage study is testing a new oral drug called TLN-254 in adults with T-cell lymphoma that has come back or hasn't responded to standard treatments. The main goals are to see if the drug shrinks tumors, how safe it is, and how the body processes it. The study will enrol…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC